Position in PTCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,719,028
+$1,243,992 QoQ
Shares Held
192,706
-9.3% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#67
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. PTCT ranks #22 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,719,028 | 192,706 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $14,475,036 | 212,462 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,795,882 | 207,950 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,990,288 | 113,904 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,789,444 | 118,539 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,697,990 | 111,813 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $5,073,781 | 112,401 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,109,604 | 110,771 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,559,389 | 116,396 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,173,195 | 109,082 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,926,486 | 106,186 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,397,959 | 107,004 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,298,086 | 105,682 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,007,242 | 103,370 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,879,369 | 101,634 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,950,673 | 98,619 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,590,137 | 89,619 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,764,036 | 74,083 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,953,593 | 74,155 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,792,275 | 75,041 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,206,179 | 75,850 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,408,537 | 71,986 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,917,553 | 80,576 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,661,366 | 78,318 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,042,033 | 99,370 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,972,698 | 89,054 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||